HemostasisHemostasis, SurgicalHemostasis, EndoscopicHemostatic TechniquesHemostaticsBleeding TimeEconomic CompetitionBlood CoagulationHealth Care SectorBlood PlateletsThrombosisBlood Coagulation DisordersHemorrhageCommerceMarketingHemostatic DisordersPlatelet ActivationThrombelastographyBlood Coagulation FactorsBlood Loss, SurgicalCellulose, OxidizedPlatelet AggregationMarketing of Health ServicesPuncturesPeptic Ulcer HemorrhageFibrinogenPostoperative HemorrhageHemorrhagic DisordersInvestmentsFibrin Tissue AdhesiveGastrointestinal HemorrhageThrombinElectrocoagulationFibrinolysisvon Willebrand FactorProthrombin TimeCoagulantsPlatelet AdhesivenessBlood Coagulation TestsPartial Thromboplastin TimeThromboplastinGelatin Sponge, AbsorbableFactor VIIaSurgical InstrumentsFactor XII DeficiencyHemophilia AFactor VIIIBlood Coagulation Factor InhibitorsPlatelet CountTissue AdhesivesFactor VIIClot RetractionFibrinDrug IndustryFemoral ArteryHealth Facility MergerAntithrombin Proteinsvon Willebrand DiseasesUnited StatesWound Closure TechniquesHematologyAntitrust LawsDisseminated Intravascular CoagulationAntithrombin IIIAnticoagulantsFibrin Fibrinogen Degradation ProductsPlatelet Membrane GlycoproteinsInsurance PoolsFibrin FoamPlatelet Glycoprotein GPIb-IX ComplexProthrombinEnbucrilateFactor XI DeficiencyCoagulation Protein DisordersSuture TechniquesInsurance Selection BiasHealth Care ReformOcclusive DressingsHematomaTampons, SurgicalEndoscopy, GastrointestinalPlatelet Function TestsTime FactorsFinancial ManagementPatents as TopicPlatelet Glycoprotein GPIIb-IIIa ComplexTreatment OutcomeEconomics, HospitalMegakaryocytesLegislation, DrugTax ExemptionFactor XIPlatelet Membrane Glycoprotein IIbFibrinopeptide ACyanoacrylatesManaged CompetitionReceptors, Proteinase-ActivatedTobacco IndustryHemophilia BAneurysm, False